You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 257 No. 2, January 9, 1987 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Risk of Breast Cancer in Postmenopausal Women Who Have Used Estrogen Replacement Therapy

Phyllis A. Wingo, MS; Peter M. Layde, MD; Nancy C. Lee, MD; George Rubin, MB, BS; Howard W. Ory, MD

JAMA. 1987;257(2):209-215.


Abstract

We studied the association between estrogen replacement therapy (ERT) and the risk of breast cancer as part of the Cancer and Steroid Hormone Study. All subjects in the analysis were postmenopausal women enrolled from eight geographic areas. Women 25 to 54 years old with newly diagnosed breast cancer were identified through population-based tumor registries and diagnosed between Dec 1,1980, and Dec 31,1982. Controls were selected from the same eight geographic areas by the random digit dialing of residential telephone numbers. Analyses included 1369 cases and 1645 controls. Among women with bilateral oophorectomy, the relative risk of breast cancer for women who had ever used ERT was 1.3, compared with women who had never used ERT. Among women who had undergone hysterectomy but who still had at least one ovary, the relative risk was 1.1; among women who reported a natural menopause, the relative risk was 0.8. Overall, the risk of breast cancer did not appear to increase appreciably with increasing ERT duration or latency, even for durations and latencies of 20 years or longer.

(JAMA 1987;257:209-215)



Author Affiliations

From the Division of Reproductive Health, Center for Health Promotion and Education (Ms Wingo and Drs Lee and Rubin), Office of the Director (Dr Layde), and Information Resources Management (Dr Ory), Centers for Disease Control, Atlanta.


Footnotes

The use of trade names is for identification only and does not imply endorsement of the product by the Public Health Service.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Postmenopausal Estrogen and Progestin Use in Relation to Breast Cancer Risk
Newcomb et al.
Cancer Epidemiol. Biomarkers Prev. 2002;11:593-600.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy in Relation to Breast Cancer
Chen et al.
JAMA 2002;287:734-741.
ABSTRACT | FULL TEXT  

The menopause and its treatment in perspective
Al-Azzawi
Postgrad. Med. J. 2001;77:292-304.
FULL TEXT  

Breast cancer hypothesis: a single cause for the majority of cases
Wiseman
J. Epidemiol. Community Health 2000;54:851-858.
ABSTRACT | FULL TEXT  

Women need to be warned about dangers of hormone replacement therapy
Price et al.
BMJ 1997;314:376-376.
FULL TEXT  

Bone Mineral Density and Risk of Breast Cancer in Older Women: The Study of Osteoporotic Fractures
Cauley et al.
JAMA 1996;276:1404-1408.
ABSTRACT  

Use of hormone replacement therapy
Mckinney
BMJ 1996;313:686-686.
FULL TEXT  

Hormone Replacement Therapy and Breast Cancer Risk
Gambrell
Arch Fam Med 1996;5:341-348.
ABSTRACT  

Postmenopausal Estrogens and Breast Cancer
Colditz
Reproductive Sciences 1996;3:50-56.
 

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
Colditz et al.
NEJM 1995;332:1589-1593.
ABSTRACT | FULL TEXT  

Estrogen Replacement Therapy in Breast Cancer Survivors: A Time for Change
Cobleigh et al.
JAMA 1994;272:540-545.
ABSTRACT  

Hormonal Treatment of Postmenopausal Women
Belchetz
NEJM 1994;330:1062-1071.
FULL TEXT  

Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady et al.
ANN INTERN MED 1992;117:1016-1037.
ABSTRACT  

The Postmenopausal Estrogen/Breast Cancer Controversy
Henrich
JAMA 1992;268:1900-1902.
ABSTRACT  

Estrogen Replacement Therapy and Risk of Breast Cancer: Results of Two Meta-analyses-Reply
Dupont and Page
Arch Intern Med 1992;152:1090-1093.
ABSTRACT  

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer
Steinberg et al.
JAMA 1991;265:1985-1990.
ABSTRACT  

Menopausal Estrogen Replacement Therapy and Breast Cancer
Dupont and Page
Arch Intern Med 1991;151:67-72.
ABSTRACT  

Prospective Study of Estrogen Replacement Therapy and Risk of Breast Cancer in Postmenopausal Women
Colditz et al.
JAMA 1990;264:2648-2653.
ABSTRACT  

Screening for Osteoporosis
Melton et al.
ANN INTERN MED 1990;112:516-528.
ABSTRACT  

Lifetime Risks of Hip, Colles', or Vertebral Fracture and Coronary Heart Disease Among White Postmenopausal Women
Cummings et al.
Arch Intern Med 1989;149:2445-2448.
ABSTRACT  

Breast Cancer in a Male-to-Female Transsexual: A Case Report
Pritchard et al.
JAMA 1988;259:2278-2280.
ABSTRACT  

Estrogens and Risk of Breast Cancer
Lemon and Foley
JAMA 1987;257:2165-2166.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.